Athenex is moving forward with a project to build a $210 million manufacturing plant in New York that will be financed primarily by the state.
Following mass immunization program halt, Dengvaxia’s marketing authorization in the Philippines has been put on hold for a year.
Chinese pharmaceutical database PharmCube highlighted 16 possible blockbuster approvals in China in 2018.
Legend teams with J&J on CAR-T project, Eisai and Biogen's Alzheimer's drug fails in early readout, Impax and Bora Pharma ink deal.
China's ApolloBio increased upfront payment, while also terminating its right to buy into Inovio.
Japan’s JSR bought Crown Biosciences, Aurobindo and Dr. Reddy’s responded to Orchid Pharma report, Tessa raised $80 million.
As Philippines lawmakers continue probing the country's now-controversial dengue immunization program, a former president has spoken up to defend it.
GlaxoSmithKline said it is cutting an undisclosed number of jobs at its Irvine plant in North Ayrshire, Scotland.
Aurobindo and Dr. Reddy’s each responded to a report by the Economic Times that said both were front-runners to buy bankrupt Orchid Pharma.
Teva Pharmaceutical is facing ongoing protests at its operations in Israel after it announced global layoffs that are expected to reach some 14,000 employees…